secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPECTRUM PHARMACEUTICALS INC (—)
CIK:        0000831547
Form:       8-K
Filed at:   2023-08-01T23:59:59+00:00
Accession:  0001193125-23-199589
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Assertio closes Spectrum acquisition; SPPI delisted from Nasdaq
---------------------------------------------------------------

- Spectrum shareholders received 0.1783 Assertio shares plus CVR for up to $0.20 per share based on ROLVEDON milestones.
- Spectrum's board (Ashton, Bradrick, Fischer, Lim, Riga, Vacirca) resigned; Jeffrey Vacirca appointed to Assertio board.
- SPPI halted after July 31 close, delisted from Nasdaq Aug 1; company plans Form 15 to suspend reporting.
- Transaction expected to be significantly accretive to Assertio in 2024; combined guidance on Q2 call Aug 3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/831547/000119312523199589/0001193125-23-199589-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/831547/000119312523199589/d332583d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-199589

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer